NantHealth (NASDAQ:NH) Coverage Initiated at StockNews.com

Analysts at StockNews.com started coverage on shares of NantHealth (NASDAQ:NH) in a research note issued on Monday. The firm set a “hold” rating on the stock.

NantHealth Stock Down 10.3 %

Shares of NantHealth stock opened at $0.61 on Monday. The stock has a market cap of $4.70 million, a price-to-earnings ratio of -0.08 and a beta of 1.82. NantHealth has a twelve month low of $1.24 and a twelve month high of $9.75. The company’s fifty day moving average is $0.36 and its 200 day moving average is $0.39.

Hedge Funds Weigh In On NantHealth

A number of hedge funds have recently bought and sold shares of NH. Susquehanna International Group LLP bought a new position in NantHealth in the 1st quarter valued at $25,000. Goldman Sachs Group Inc. bought a new stake in NantHealth in the second quarter worth about $36,000. Millennium Management LLC purchased a new position in NantHealth in the second quarter valued at about $110,000. Finally, Atria Wealth Solutions Inc. increased its stake in shares of NantHealth by 117.7% during the 2nd quarter. Atria Wealth Solutions Inc. now owns 491,942 shares of the company’s stock worth $205,000 after purchasing an additional 265,949 shares during the last quarter. 4.50% of the stock is owned by hedge funds and other institutional investors.

About NantHealth

NantHealth, Inc engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management.